We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+15.03%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
10 Year Est. Return
AUM
$113M
AUM Growth
+$13.8M
Cap. Flow
-$191K
Cap. Flow %
-0.17%
Top 10 Hldgs %
20.9%
Holding
65
New
2
Increased
55
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$1.91M
2
O icon
Realty Income
O
+$630K
3
CI icon
Cigna
CI
+$254K
4
GILD icon
Gilead Sciences
GILD
+$64.5K
5
MRK icon
Merck
MRK
+$63.4K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.93M
2
STOR
STORE Capital Corporation
STOR
+$1.24M
3
WBA
Walgreens Boots Alliance
WBA
+$1.21M
4
AFL icon
Aflac
AFL
+$372K
5
AMGN icon
Amgen
AMGN
+$291K

Sector Composition

Rank Sector Weight
1 Financials 21.34%
2 Healthcare 18.18%
3 Industrials 10.72%
4 Energy 10.01%
5 Technology 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRP icon
51
TC Energy
TRP
$66.3B
$1.48M 1.3%
37,120
+652
+2% +$28.3K
EMN icon
52
Eastman Chemical
EMN
$8.55B
$1.45M 1.28%
17,857
+455
+3% +$36.7K
VZ icon
53
Verizon
VZ
$196B
$1.45M 1.28%
36,740
+730
+2% +$27.5K
TSN icon
54
Tyson Foods
TSN
$19.9B
$1.39M 1.23%
22,328
+572
+3% +$37.2K
MPC icon
55
Marathon Petroleum
MPC
$94.5B
$1.29M 1.14%
11,121
+284
+3% +$32.4K
TFC icon
56
Truist Financial
TFC
$63.9B
$1.27M 1.12%
29,506
+463
+2% +$20.3K
MDT icon
57
Medtronic
MDT
$116B
$1.23M 1.09%
15,872
+355
+2% +$28.8K
TROW icon
58
T. Rowe Price
TROW
$24.3B
$1.09M 0.96%
9,958
+254
+3% +$28.7K
OHI icon
59
Omega Healthcare
OHI
$13.8B
$1.04M 0.92%
37,270
+937
+3% +$28.3K
T icon
60
AT&T
T
$168B
$879K 0.77%
47,748
+1,230
+3% +$22K
CI icon
61
Cigna
CI
$72.4B
$266K 0.23%
+803
New +$254K
CAH icon
62
Cardinal Health
CAH
$56.3B
$241K 0.21%
3,133
-553
-15% -$42K
AAPL icon
63
Apple
AAPL
$4.45T
-13,937
Closed -$1.93M
WBA
64
DELISTED
Walgreens Boots Alliance
WBA
-38,616
Closed -$1.21M
STOR
65
DELISTED
STORE Capital Corporation
STOR
-39,459
Closed -$1.24M

Similar funds

Weaver C. Barksdale & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Weaver C. Barksdale & Associates held 65 positions worth $113M, up 14% from $99.7M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Weaver C. Barksdale & Associates's Q4 2022 filing shows 2 new, 55 increased, 5 reduced and 3 closed positions. Its largest new stake was Crown Castle: 14,155 shares worth $1.92M. The largest sale was Apple, an estimated $1.93M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Weaver C. Barksdale & Associates's largest Q4 2022 buy was Crown Castle: 14,155 shares worth $1.92M.
  • Weaver C. Barksdale & Associates added most to Realty Income in Q4 2022, an estimated $630K increase.
  • Weaver C. Barksdale & Associates's biggest Q4 2022 reduction was Aflac, cutting an estimated $372K.
  • Weaver C. Barksdale & Associates fully exited Apple in Q4 2022, selling an estimated $1.93M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 21% of its $113M portfolio in Q4 2022.
  • Weaver C. Barksdale & Associates opened 2 new positions and closed 3 in Q4 2022.
  • Weaver C. Barksdale & Associates's portfolio value rose 14% quarter-over-quarter to $113M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2022, filed 14 Feb 2023.